Which has the lower trailing P/E, ANAB or NUTX?

NUTX has the lower trailing P/E: ANAB trades at 8.97 and NUTX at 8.81. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ANAB or NUTX?

Over the past five years, NUTX grew revenue faster — ANAB at a 18.60% CAGR versus NUTX at 37.66%.

Is ANAB or NUTX more profitable?

ANAB runs the higher net margin — ANAB at 82.37% versus NUTX at 21.25%.

How have ANAB and NUTX total returns compared?

Over the past 5 years, ANAB delivered 21.54% and NUTX delivered -18.99% annualized total return. Past performance doesn't predict future results.

AnaptysBio, Inc. (ANAB) vs Nutex Health, Inc. (NUTX)

A side-by-side comparison of AnaptysBio, Inc. and Nutex Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANAB

AnaptysBio, Inc.

$1.43B

$48.19HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT

NUTX

Nutex Health, Inc.

$1.53B

$222.81HealthcareDelayed quote: Oct 6, 2026, 12:05 PM EDT

Total return — ANAB vs NUTX

growth of $100 · dividends reinvested · last 10y

ANAB +334.2% (+15.8%/yr)NUTX -94.9% (-25.8%/yr)ANAB compounded faster over this window

Log scale — wide-divergence pair

ANAB NUTX

ANAB vs NUTX: by the numbers

•NUTX is the larger company ($1.53B vs $1.43B market cap).
•NUTX trades at the lower trailing earnings multiple (8.81 vs 8.97 P/E), one valuation lens rather than an overall verdict.
•ANAB converts more revenue to profit (82.37% vs 21.25% net margin).
•NUTX grew revenue faster over the past five years (37.66% vs 18.60% CAGR).

Metrics side by side

Valuation

Metric	ANAB	NUTX
P/E ratio	8.97	8.81
Forward P/E	N/A	8.02
P/S ratio	6.00	1.81
P/B ratio	134.80	3.89
EV / EBITDA	11.51	4.35
FCF yield	1.26%	17.88%

Profitability

Metric	ANAB	NUTX
Gross margin	98.97%	51.26%
Operating margin	20.42%	31.49%
Net margin	82.37%	21.25%
ROE	1849.06%	45.63%
ROIC	47.55%	33.76%

Growth (annualized)

Metric	ANAB	NUTX
Revenue CAGR (5Y)	18.60%	37.66%
EPS CAGR (5Y)	N/A	-14.73%
FCF CAGR (5Y)	27.41%	N/A
Total return CAGR (5Y)	21.54%	-18.99%

Frequently asked

Which has the lower trailing P/E, ANAB or NUTX?: NUTX has the lower trailing P/E: ANAB trades at 8.97 and NUTX at 8.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ANAB or NUTX?: Over the past five years, NUTX grew revenue faster — ANAB at a 18.60% CAGR versus NUTX at 37.66%.
Is ANAB or NUTX more profitable?: ANAB runs the higher net margin — ANAB at 82.37% versus NUTX at 21.25%.
How have ANAB and NUTX total returns compared?: Over the past 5 years, ANAB delivered 21.54% and NUTX delivered -18.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANAB analysis Full NUTX analysis Interactive comparison tool

Dig into the metrics

AnaptysBio P/E ratio Nutex Health P/E ratio AnaptysBio ROE Nutex Health ROE AnaptysBio operating margin Nutex Health operating margin AnaptysBio revenue growth Nutex Health revenue growth AnaptysBio free cash flow Nutex Health free cash flow

AnaptysBio & Nutex Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.